Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research-Reference-Cited by-同舟云学术

Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research

Published:2017-05 Issue: Volume:152 Page:114-130
ISSN:0301-0082
Container-title:Progress in Neurobiology
language:en
Short-container-title:Progress in Neurobiology

Author:

Grossman Iris,Knappertz Volker,Laifenfeld Daphna,Ross Colin,Zeskind Ben,Kolitz Sarah,Ladkani David,Hayardeny Liat,Loupe Pippa,Laufer Ralph,Hayden Michael

Publisher

Elsevier BV

Subject

General Neuroscience

Reference137 articles.

1. Cognitive resilience in multiple sclerosis: characterization of blood gene expression profiles associated with preserved cognitive function;Achiron;Neurology,2014

2. Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis;Achiron;Dis. Markers,2009

3. Copolymer 1 acts against the immunodominant epitope 82–100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking;Aharoni;Proc. Natl. Acad. Sci. U.S.A.,1999

4. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ;Aharoni;Proc. Natl. Acad. Sci. U.S.A.,2003

5. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice;Aharoni;Proc. Natl. Acad. Sci. U.S.A.,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association study;Journal of Neurology;2024-09-12

2. Predicting disease severity in multiple sclerosis using multimodal data and machine learning;Journal of Neurology;2023-12-22

3. Blocking the IFN‐gamma signal in the choroid plexus confers resistance to experimental autoimmune encephalomyelitis;The FASEB Journal;2023-03-15

4. Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning;2023-01-05

5. Literatur;Multiple Sklerose;2022